Simethicone for Post-Gastric Bypass Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery.The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Are You a Good Fit for This Trial?
This trial is for patients undergoing foregut procedures, including bariatric surgeries like sleeve gastrectomy and Roux-en-Y gastric bypass, as well as hiatal hernia and other gastric surgeries. It aims to see if simethicone can help with gas pain and bloating after surgery.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo surgical procedures and receive either simethicone or placebo for 14 days postoperatively
Follow-up
Participants are monitored for safety and effectiveness after treatment, including completion of surveys at follow-up visit
Data Collection and Analysis
Data is collected, de-identified, and analyzed for reporting
What Are the Treatments Tested in This Trial?
Interventions
- Simethicone
Find a Clinic Near You
Who Is Running the Clinical Trial?
Madigan Army Medical Center
Lead Sponsor